Advertisement
Health care spending growth slowed in 2016 following faster growth in 2014 and 2015

Deceleration in Health Care Spending Growth in 2016

0
Enrollment trends drove slowdown in Medicaid and private health insurance spending growth in 2016
Previous findings that systemic use of antibiotics increases the risk of diabetes may actually be explained by clinical and lifestyle factors

Link Between Diabetes, Antibiotic Use Called Into Question

0
Clinical, lifestyle factors may have confounded previous findings linking antibiotics, diabetes risk
CVS Health's planned purchase of insurance giant Aetna

CVS-Aetna Merger Has Implications for Doctors’ Offices

0
More health services will likely move out of doctors' offices to store-based providers
Nivolumab treatment for non-small-cell lung cancer may induce successful depletion of HIV reservoir

Nivolumab May Induce Successful Depletion of HIV Reservoir

0
Case report describes smoker with HIV infection receiving nivolumab for non-small-cell lung cancer

November 2017 Briefing – Infectious Disease

0
Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for November 2017. This roundup includes the...
The incidence of HIV infection declined significantly in Uganda between 1999 and 2016

Incidence of HIV Dropped From 1999 to 2016 in Uganda

0
Drop in incidence coincided with increases in ART coverage, male circumcision, teens not having sex
For patients with recurrent Clostridium difficile infection

Fecal Microbial Transplant by Oral Capsule Noninferior for CDI

0
FMT by capsule noninferior to FMT by colonoscopy for prevention of recurrent C. difficile infection
For patients with human papillomavirus-associated cancers

Sex, Race, Age Disparities in Survival for HPV-Linked Cancer

0
Whites have consistently higher five-year survival than blacks for all cancers across all age groups
For infants with bronchiolitis

Practice Variation in Treatment for Bronchiolitis in Infants

0
Variation in evidence-based supportive therapies by site, ranging from 6 to 99 percent
The five-year risks of cervical intraepithelial neoplasia grade 3 (CIN3)

Risk of ≥CIN3 Drops With Negative HPV, Cytology Co-Tests

0
Decrease in 5-year ≥CIN3 risks after each successive negative round of HPV, cytology co-testing